The ERISA Industry Committee Urges Rejection of New Jersey Health Care Bill

WASHINGTON, June 22, 2023 – The ERISA Industry Committee (ERIC) today submitted written testimony in opposition to New Jersey Assembly Bill 536/2841, asserting the legislation under consideration by the New Jersey Assembly Appropriations Committee oversteps state authority and seeks to control self-insured employer health care plans governed by the federal Employee Retirement Income Security Act of 1974 (ERISA). ERIC believes that the legislation would raise health insurance and prescription drug costs for New Jersey employers and employees.

The ERISA Industry Committee Concerned North Carolina Pharmacy Benefit Manager Legislation Oversteps State Authority, Violates Federal Law

WASHINGTON, June 1, 2023 – The ERISA Industry Committee (ERIC) today said it has “deep concerns” with North Carolina House Bill 246 and the expansive regulation of pharmacy benefit managers (PBMs) that it proposes. Namely, the bill contains several provisions that seek to control the design and administration of self-insured employer health plans governed solely by the federal Employee Retirement Income Security Act of 1974 (ERISA), which PBMs often administer. To highlight the negative impacts posed by HB 246, ERIC developed a legislative outlook memo to better inform advocacy organizations and stakeholder groups also engaged on this statewide effort.

The ERISA Industry Committee Leads Coalition Amicus Brief Supporting Legal Challenge to Oklahoma Law on ERISA Preemption Grounds

WASHINGTON, April 11, 2023 – The ERISA Industry Committee (ERIC) joined with like-minded coalition groups yesterday to file an amicus brief supporting the legal fight to defeat expansive provisions of Oklahoma law governing the design of employer health plans’ provider networks. These provisions overstep state authority in this area and should be preempted by federal law.